Container closure systems do not provide adequate protection against foreseeable external factors in storage and use that can cause deterioration or contamination ofthe (©) @product.
Inspection Record
SAFC Pharma Carlsbad — FDA 483 Findings
Inspectors Arie C. MenachemThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Establishment ofthe reliability of the component supplier's report of analyses is deficient in that the test results are not appropriately validated at appropriate intervals.
Routine calibration of equipment is not performed according to a written program designed to assure proper performance.
Procedures designed to prevent microbiological contamination of pi products purporting to be sterile are not established, written, or followed.
Written procedures are not approved by the appropriate organizational units.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- RC Outsourcing LLC2016-03-18 · US FDASimilar to finding 3 Routine calibration of equipment is not performed according to a written program designed to assure proper performance.
- Newton Laboratories, Inc.2026-03-26 · US FDASimilar to finding 1 Container closure systems do not provide adequate protection against foreseeable external factors in storage and use that can cause deterioration or…
- Barr Laboratories Inc.2025-05-09 · US FDASimilar to finding 5 Written procedures are not drafted, reviewed and approved by the appropriate organizational units.
- Wells Pharmacy Inc.2025-04-25 · US FDASimilar to finding 1 Container closure systems do not provide adequate protection against foreseeable external factors in storage and use that can cause deterioration or…
- ADMA Biologics, Inc2024-12-11 · US FDASimilar to finding 4 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written and followed.
A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.